Production (Stage)
Galera Therapeutics, Inc.
GRTX
$0.0326
$0.005118.55%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.69M | 8.29M | 8.46M | 10.75M | 13.47M |
| Total Receivables | -- | 635.00K | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 874.00K | 1.08M | 444.00K | 1.21M | 1.72M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.56M | 10.00M | 8.90M | 11.96M | 15.19M |
|
|
|||||
| Total Current Assets | 7.56M | 10.00M | 8.90M | 11.96M | 15.19M |
| Net Property, Plant & Equipment | -- | -- | -- | 1.19M | 1.24M |
| Long-term Investments | -- | -- | -- | 881.00K | 881.00K |
| Goodwill | -- | -- | -- | 881.00K | 881.00K |
| Total Other Intangibles | -- | -- | -- | 2.26M | 2.26M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 101.00K | 100.00K | 2.00K | 90.00K | 90.00K |
| Total Assets | 7.66M | 10.10M | 8.90M | 16.38M | 19.65M |
|
|
|||||
| Total Accounts Payable | 744.00K | 1.28M | 296.00K | 812.00K | 1.05M |
| Total Accrued Expenses | 231.00K | 391.00K | 618.00K | 1.16M | 831.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 157.00K | 136.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 975.00K | 1.67M | 914.00K | 2.13M | 2.01M |
|
|
|||||
| Total Current Liabilities | 975.00K | 1.67M | 914.00K | 2.13M | 2.01M |
| Long-Term Debt | 151.05M | 151.05M | 151.05M | 151.05M | 151.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 1.04M | 1.08M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 1.06M | -- | 203.00K | 203.00K |
| Total Liabilities | 152.02M | 153.77M | 151.96M | 154.42M | 154.34M |
|
|
|||||
| Common Stock & APIC | 310.73M | 308.32M | 308.37M | 307.82M | 307.10M |
| Retained Earnings | -457.96M | -456.36M | -451.43M | -445.85M | -441.79M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -147.23M | -148.04M | -143.06M | -138.03M | -134.69M |
|
|
|||||
| Preferred Stock Redeemable | 2.86M | 4.37M | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.86M | 4.37M | -- | -- | -- |
|
|
|||||
| Total Common Equity | -147.23M | -148.04M | -143.06M | -138.03M | -134.69M |
| Total Preferred Equity | 2.86M | 4.37M | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -144.36M | -143.67M | -143.06M | -138.03M | -134.69M |
|
|
|||||